108 related articles for article (PubMed ID: 27784775)
1. Expanding the phenotype of BICD2 mutations toward skeletal muscle involvement.
Unger A; Dekomien G; Güttsches A; Dreps T; Kley R; Tegenthoff M; Ferbert A; Weis J; Heyer C; Linke WA; Martinez-Carrera L; Storbeck M; Wirth B; Hoffjan S; Vorgerd M
Neurology; 2016 Nov; 87(21):2235-2243. PubMed ID: 27784775
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.
Rossor AM; Oates EC; Salter HK; Liu Y; Murphy SM; Schule R; Gonzalez MA; Scoto M; Phadke R; Sewry CA; Houlden H; Jordanova A; Tournev I; Chamova T; Litvinenko I; Zuchner S; Herrmann DN; Blake J; Sowden JE; Acsadi G; Rodriguez ML; Menezes MP; Clarke NF; Auer Grumbach M; Bullock SL; Muntoni F; Reilly MM; North KN
Brain; 2015 Feb; 138(Pt 2):293-310. PubMed ID: 25497877
[TBL] [Abstract][Full Text] [Related]
3. Autosomal dominant spinal muscular atrophy with lower extremity predominance: A recognizable phenotype of BICD2 mutations.
Rudnik-Schöneborn S; Deden F; Eggermann K; Eggermann T; Wieczorek D; Sellhaus B; Yamoah A; Goswami A; Claeys KG; Weis J; Zerres K
Muscle Nerve; 2016 Sep; 54(3):496-500. PubMed ID: 26998597
[TBL] [Abstract][Full Text] [Related]
4. Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy.
Neveling K; Martinez-Carrera LA; Hölker I; Heister A; Verrips A; Hosseini-Barkooie SM; Gilissen C; Vermeer S; Pennings M; Meijer R; te Riele M; Frijns CJ; Suchowersky O; MacLaren L; Rudnik-Schöneborn S; Sinke RJ; Zerres K; Lowry RB; Lemmink HH; Garbes L; Veltman JA; Schelhaas HJ; Scheffer H; Wirth B
Am J Hum Genet; 2013 Jun; 92(6):946-54. PubMed ID: 23664116
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic extremes of BICD2-opathies: from lethal, congenital muscular atrophy with arthrogryposis to asymptomatic with subclinical features.
Storbeck M; Horsberg Eriksen B; Unger A; Hölker I; Aukrust I; Martínez-Carrera LA; Linke WA; Ferbert A; Heller R; Vorgerd M; Houge G; Wirth B
Eur J Hum Genet; 2017 Sep; 25(9):1040-1048. PubMed ID: 28635954
[TBL] [Abstract][Full Text] [Related]
6. Molecular defects in the motor adaptor BICD2 cause proximal spinal muscular atrophy with autosomal-dominant inheritance.
Peeters K; Litvinenko I; Asselbergh B; Almeida-Souza L; Chamova T; Geuens T; Ydens E; Zimoń M; Irobi J; De Vriendt E; De Winter V; Ooms T; Timmerman V; Tournev I; Jordanova A
Am J Hum Genet; 2013 Jun; 92(6):955-64. PubMed ID: 23664119
[TBL] [Abstract][Full Text] [Related]
7. Adult-onset SMALED2 due to a novel
Wan C; Wang Y; Zhou Q; Yu Y; Hong D; Zhu M
Clin Neuropathol; 2019; 38(3):109-117. PubMed ID: 30738493
[TBL] [Abstract][Full Text] [Related]
8. Novel BICD2 mutation in a Japanese family with autosomal dominant lower extremity-predominant spinal muscular atrophy-2.
Yoshioka M; Morisada N; Toyoshima D; Yoshimura H; Nishio H; Iijima K; Takeshima Y; Uehara T; Kosaki K
Brain Dev; 2018 Apr; 40(4):343-347. PubMed ID: 29273277
[TBL] [Abstract][Full Text] [Related]
9. Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia.
Oates EC; Rossor AM; Hafezparast M; Gonzalez M; Speziani F; MacArthur DG; Lek M; Cottenie E; Scoto M; Foley AR; Hurles M; Houlden H; Greensmith L; Auer-Grumbach M; Pieber TR; Strom TM; Schule R; Herrmann DN; Sowden JE; Acsadi G; Menezes MP; Clarke NF; Züchner S; ; Muntoni F; North KN; Reilly MM
Am J Hum Genet; 2013 Jun; 92(6):965-73. PubMed ID: 23664120
[TBL] [Abstract][Full Text] [Related]
10. BICD2 mutational analysis in hereditary spastic paraplegia and hereditary motor and sensory neuropathy.
Kropatsch R; Schmidt HM; Buttkereit P; Epplen JT; Hoffjan S
Muscle Nerve; 2019 Apr; 59(4):484-486. PubMed ID: 30536747
[TBL] [Abstract][Full Text] [Related]
11. Microscopic and Biochemical Hallmarks of
Unger A; Roos A; Gangfuß A; Hentschel A; Gläser D; Krause K; Doering K; Schara-Schmidt U; Hoffjan S; Vorgerd M; Güttsches AK
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047781
[No Abstract] [Full Text] [Related]
12. Clinical spectrum of BICD2 mutations.
Frasquet M; Camacho A; Vílchez R; Argente-Escrig H; Millet E; Vázquez-Costa JF; Silla R; Sánchez-Monteagudo A; Vílchez JJ; Espinós C; Lupo V; Sevilla T
Eur J Neurol; 2020 Jul; 27(7):1327-1335. PubMed ID: 32056343
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into SMALED2: BICD2 mutations increase microtubule stability and cause defects in axonal and NMJ development.
Martinez Carrera LA; Gabriel E; Donohoe CD; Hölker I; Mariappan A; Storbeck M; Uhlirova M; Gopalakrishnan J; Wirth B
Hum Mol Genet; 2018 May; 27(10):1772-1784. PubMed ID: 29528393
[TBL] [Abstract][Full Text] [Related]
14. SMALED2 with BICD2 gene mutations: Report of two cases and portrayal of a classical phenotype.
Picher-Martel V; Morin C; Brunet D; Dionne A
Neuromuscul Disord; 2020 Aug; 30(8):669-673. PubMed ID: 32709491
[TBL] [Abstract][Full Text] [Related]
15. Disease-associated mutations in human BICD2 hyperactivate motility of dynein-dynactin.
Huynh W; Vale RD
J Cell Biol; 2017 Oct; 216(10):3051-3060. PubMed ID: 28883039
[TBL] [Abstract][Full Text] [Related]
16. A case of severe autosomal dominant spinal muscular atrophy with lower extremity predominance caused by a de novo BICD2 mutation.
Ueda Y; Suganuma T; Narumi-Kishimoto Y; Kaname T; Sato T
Brain Dev; 2021 Jan; 43(1):135-139. PubMed ID: 32888736
[TBL] [Abstract][Full Text] [Related]
17. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy.
Rossor AM; Sleigh JN; Groves M; Muntoni F; Reilly MM; Hoogenraad CC; Schiavo G
Acta Neuropathol Commun; 2020 Mar; 8(1):34. PubMed ID: 32183910
[TBL] [Abstract][Full Text] [Related]
18. The Genotypic and Phenotypic Spectrum of BICD2 Variants in Spinal Muscular Atrophy.
Koboldt DC; Waldrop MA; Wilson RK; Flanigan KM
Ann Neurol; 2020 Apr; 87(4):487-496. PubMed ID: 32057122
[TBL] [Abstract][Full Text] [Related]
19. Recurrent de novo BICD2 mutation associated with arthrogryposis multiplex congenita and bilateral perisylvian polymicrogyria.
Ravenscroft G; Di Donato N; Hahn G; Davis MR; Craven PD; Poke G; Neas KR; Neuhann TM; Dobyns WB; Laing NG
Neuromuscul Disord; 2016 Nov; 26(11):744-748. PubMed ID: 27751653
[TBL] [Abstract][Full Text] [Related]
20. In-frame de novo mutation in
Koboldt DC; Kastury RD; Waldrop MA; Kelly BJ; Mosher TM; McLaughlin H; Corsmeier D; Slaughter JL; Flanigan KM; McBride KL; Mehta L; Wilson RK; White P
Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30054298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
